Protein-expression profiles in mouse blood-plasma following acute whole-body exposure to 137Cs rays

International Journal of Radiation Biology

Volumn 85, Issue 5, 2009, Pages 432-447

  Rithidech, Kanokporn Noy ^a   Honikel, Louise ^a   Rieger, Robert ^a   Xie, Weiping ^a,b   Fischer, Thomas ^a   Simon, Sanford R ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b PDL BioPharma Inc   (United States)

Author keywords

Blood plasma; Mouse; Protein expression profiles; Proteomics; Radiation

Indexed keywords

ALPHA 1 ANTITRYPSIN PRECURSOR; ALPHA 2 HEREMAN SCHMID GLYCOPROTEIN; APOLIPOPROTEIN A4; APOLIPOPROTEIN AII PRECURSOR; APOLIPOPROTEIN E; BETA2 GLYCOPROTEIN 1; CARBOXYLESTERASE N; CESIUM 137; CHOLESTEROL 7ALPHA MONOOXYGENASE; CLUSTERIN; COAGULATION FACTOR 13; FIBRINOGEN A ALPHA CHAIN; FIBRINOGEN GAMMA POLYPEPTIDE; GELSOLIN; HAPTOGLOBIN; HIGH MOLECULAR WEIGHT KININOGEN; LIVER CARBOXYLESTERASE I PRECURSOR; LOW MOLECULAR WEIGHT KININOGEN; MAJOR URINARY PROTEIN 6 PRECURSOR; MANNOSE BINDING LECTIN C; MANNOSE BINDING PROTEIN C PRECURSOR; NEUREXIN; PHOSPHOPROTEIN PHOSPHATASE; PREPROTHROMBIN; PROTEIN; PROTEIN PRECURSOR; PROTHROMBIN; PUTATIVE CALCIUM INFLUX CHANNEL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D BINDING PROTEIN; CESIUM; PLASMA PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; COMPUTER PROGRAM; CONTROLLED STUDY; GAMMA RADIATION; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WHOLE BODY RADIATION; ANIMAL; CATTLE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; METABOLISM; PROTEOMICS;

MUS;

ANIMALS; BLOOD PROTEINS; CATTLE; CESIUM RADIOISOTOPES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GAMMA RAYS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; MASS SPECTROMETRY; MICE; PROTEOMICS; RADIATION DOSAGE; WHOLE-BODY IRRADIATION;

EID: 67649891288     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000902820390     Document Type: Article

References (73)

1. Alves JD, Ames PR. 2003. Atherosclerosis, oxidative stress and auto-antibodies in systemic lupus erythematosus and primary antiphospholipid syndrome. Immunobiology 207(1):23-28.
2. Anderson NL, Anderson NG. 2002. The human plasma proteome: History, character, and diagnostic prospects. Molecular Cellular Proteomics 1(11):845-867.
3. Araki S, Israel S, Leskov KS, Criswell TL, Beman M, Klokov DY, Sampalth L, Reinicke KE, Cataldo E, Mayo LD, Boothman DA. 2005. Clusterin proteins: Stress-inducible polypeptides with proposed functions in multiple organ dysfunction. British Journal Radiology Supplement 27(1): 106-113.
4. Barter PJ, Nicholls S, Rye K-A, Anantharamaiah GM, Navab M, Fogelman AM. 2004. Anti-inflammatory properties of HDL. Circular Research 95(8):764-772.
5. Bhat VB, Choi MH, Wishnok JS, Tannenbaum SR. 2005. Comparative plasma proteome analysis of lymphoma-bearing SJL mice. Journal of Proteome Research 4(5):1814-1825.
6. Bouffler SD, Meijne EI, Morris DJ, Papworth D. 1997. Chromosome 2 hypersensitivity and clonal development in murine radiation acute myeloid leukaemia. International Journal of Radiation Biology 72(2):181-189.
7. Boulton E, Cleary H, Papworth D, Plumb M. 2001. Susceptibility to radiation-induced leukaemia/lymphoma is genetically separable from sensitivity to radiation-induced genomic instability. International Journal of Radiation Biology 77(1): 21-29.
8. Boulton E, Cole C, Knight A, Cleary H, Snowden R, Plumb M. 2003. Low-penetrance genetic susceptibility and resistance loci implicated in the relative risk for radiation-induced acute myeloid leukemia in mice. Blood 101(6):2349-2354.
9. Brooks AL. 1999. Biomarkers of exposure, sensitivity and disease. International Journal of Radiation Biology 75(12):1481-1503.
10. Celis JE, Kruhoffer M, Gromova I, Frederiksen C, Ostergaard M, Thykjaer T, Gromov P, Yu J, Palsdottir H, Magnusson N, Orntoft TF. 2000. Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics. Federation of European Biochemical Societies (FEBS) Letters 480(1):2-16.
11. Chen C, Boylan MT, Evans CA, Whetton AD, Wright EG. 2005. Application of two-dimensional difference gel electrophoresis to studying bone marrow macrophages and their in vivo responses to ionizing radiation. Journal of Proteome Research 4(4):1371-1380.
12. Christofidou-Solomidou M, Scherpereel A, Solomides CC, Muzykantov VR, Machtay M, Albelda SM, DiNubile MJ. 2002. Changes in plasma gelsolin concentration during acute oxidant lung injury in mice. Lung 180(2):91-104.
13. Colman RW, Sartor RB, Adam AA, DeLa Cadena RA, Stadnicki A. 1998. The plasma kallikrein-kinin system in sepsis, inflammatory arthritis, and enterocolitis. Clinical Reviews in Allergy & Immunology 16(4):365-384.
14. Dahl B. 2005. The extracellular actin scavenger system in trauma and major surgery. Clinical and experimental studies. Acta Orthopaedica, Supplement 76(317):2-24.
15. Dahl B, Schiodt FV, Ott P, Gvozdenovic R, Yin HL, Lee WM. 1999. Plasma gelsolin is reduced in trauma patients. Shock 12(2):102-104.
16. Dahl B, Schiodt FV, Ott P, Wians F, Lee WM, Balko J, O'Keefe GE. 2003. Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury. Critical Care Medicine 31(1):152-156.
17. Deininger MW, Bose S, Gora-Tybor J, Yan XH, Goldman JM, Melo JV. 1998. Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation. Cancer Research 58(3):421-425.
18. Duan X, Yarmush D, Berthiaume F, Jayaraman A, Yarmush M. 2004. A mouse serum two-dimensional gel map: Application to profiling burn injury and infection. Electrophoresis 25(17): 3055-3065.
19. Duan X, Yarmush D, Berthiaume F, Jayaraman A, Yarmush ML. 2005. Immunodepletion of albumin for two-dimensional gel detection of new mouse acute-phase protein and other plasma proteins. Proteomics 5(15):3991-4000.
20. Frost F, Roach MJ, Kushner I, Schreiber P. 2005. Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury. Archives of Physical Medicine and Rehabilitation 86(2):312-317.
21. Gianazza E. 1995. Isoelectric focusing as a tool for the investigation of post-translational processing and chemical modifications of proteins. Journal of Chromatography A 705(1):67-87.
22. Goltry KL, Epperly MW, Greenberger JS. 1998. Induction of serum amyloid A inflammatory response genes in irradiated bone marrow cells. Radiation Research 149(6):570-578.
23. Granger J, Siddiqui J, Copeland S, Remick D. 2005. Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics 5(18):4713-4718.
24. Gygi SP, Aebersold R. 2000. Mass spectrometry and proteomics. Current Opinion in Chemical Biology 4(5):489-494.
25. Gygi SP, Rochon Y, Franza BR, Aebersold R. 1999. Correlation between protein and mRNA abundance in yeast. Molecular and Cellular Biology 19(3):1720-1730.
26. Haddad JG, Harper KD, Guoth M, Pietra GG, Sanger JW. 1990. Angiopathic consequences of saturating the plasma scavenger system for actin. Proceedings of National Academy of Sciences 87(4):1381-1385.
27. Hayata I, Ishihara T, Hirashima K, Sado T, Yamagiwa J. 1979. Partial deletion of chromosome No. 2 in myelocytic leukemias of irradiated C3H/He and RFM mice. Journal of National Cancer Institute 63(3):843-848.
28. Hong JH, Chiang CS, Campbell IL, Sun JR, Withers HR, McBride WH. 1995. Induction of acute phase gene expression by brain irradiation. International Journal of Radiation Oncology, Biology, Physics 33(3):619-626.
29. Hosoi Y, Miyachi H, Matsumoto Y, Enomoto A, Nakagawa K, Suzuki N, Ono T. 2001. Induction of interleukin-1beta and interleukin-6 mRNA by low doses of ionizing radiation in macrophages. International Journal of Cancer 96(5):270-276.
30. Hu Y, Malone JP, Fagan AM, Townsend RR, Holtzman DM. 2005. Comparative proteomic analysis of intra- and inter-individual variation in human cerebrospinal fluid. Molecular and Cellular Proteomics 4(12):2000-2009.
31. Jacobs JM, Adkins JN, Qian WJ, Liu T, Shen Y, Camp DG, 2nd, Smith RD. 2005. Utilizing human blood plasma for proteomic biomarker discovery. Journal of Proteome Research 4(4): 1073-1085.
32. Joseph RE, Radhakrishnan J, Appel GB. 2001. Antiphospholipid antibody syndrome and renal disease. Current Opinion in Nephrology & Hypertension 10(2):175-181.
33. Khovidhunkit W, Duchateau PN, Medzihradszky KF, Moser AH, Naya-Vigne J, Shigenaga JK, Kane JP, Grunfeld C, Feingold KR. 2004. Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL. Atherosclerosis 176(1): 37-44.
34. Kinter M, Sherman NE. 2002. Protein sequencing and identification using tandem mass spectrometry. In: Desiderio DM, Nibbering NM, editor. New York: Wiley Interscience.
35. Klokov D, Criswell T, Leskov KS, Araki S, Mayo L, Boothman DA. 2004. IR-inducible clusterin gene expression: A protein with potential roles in ionizing radiation-induced adaptive responses, genomic instability, and bystander effects. Mutation Research 568(1):97-110.
36. Kushner I. 1998. Semantics, inflammation, cytokines and common sense. Cytokine & Growth Factor Reviews 9(3-4):191-196.
37. Kushner I, Mackiewicz A. 1987. Acute phase proteins as disease markers. Disease Markers 5(1):1-11.
38. Kwak J-Y, Ma T-Z, Yoo M-J, Hee Choi B, Kim H-G, Kim S-R, Yim C-Y, Kwak Y-G. 2004. The comparative analysis of serum proteomes for the discovery of biomarkers for acute myeloid leukemia. Experimental Hematology 32(9):836-842.
39. Lee H-J, Lee E-Y, Kwon M-S, Paik Y-K. 2006. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics. Current Opinion in Chemical Biology 10(1):42-49.
40. Lee WM. 1994. Acute liver failure. American Journal of Medicine 96(1A):3S-9S.
41. Lee WM, Galbraith RM. 1992. The extracellular actin-scavenger system and actin toxicity. New England Journal of Medicine 326(20):1335-1341.
42. Lian Z, Wang L, Yamaga S, Bonds W, Beazer-Barclay Y, Kluger Y, Gerstein M, Newburger PE, Berliner N, Weissman SM. 2001. Genomic and proteomic analysis of the myeloid differentiation program. Blood 98(3):513-524.
43. Lind SE, Smith DB, Janmey PA, Stossel TP. 1988. Depression of gelsolin levels and detection of gelsolin-actin complexes in plasma of patients with acute lung injury. American Review of Respiratory Disease 138(2):429-434.
44. Loos BG. 2005. Systemic markers of inflammation in period-ontitis. Journal of Periodontology 76(11 Suppl.):2106-2115.
45. Magic Z, Matic-Ivanovic S, Savic J, Poznanovic G. 1995. Ionizing radiation-induced expression of the genes associated with the acute response to injury in the rat. Radiation Research 143(2): 187-193.
46. Marchetti F, Coleman MA, Jones IM, Wyrobek AJ. 2006. Candidate protein biodosimeters of human exposure to ionizing radiation. International Journal of Radiation Biology 82(9):605-639.
47. Marquette C, Linard C, Galonnier M, Van Uye A, Mathieu J, Gourmelon P, Clarencon D. 2003. IL-1beta, TNFalpha and IL-6 induction in the rat brain after partial-body irradiation: Role of vagal afferents. International Journal of Radiation Biology 79(10):777-785.
48. McGale P, Darby SC. 2005. Low doses of ionizing radiation and circulatory diseases: a systematic review of the published epidemiological evidence. Radiation Research 163(3): 247-257.
49. Menard C, Johann D, Lowenthal M, Muanza T, Sproull M, Ross S, Gulley J, Petricoin E, Coleman CN, Whiteley G, Liotta L, Camphausen K. 2006. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Research 66(3):1844-1850.
50. Mizutani N, Fujikura Y, Wang YH, Tamechika M, Tokuda N, Sawada T, Fukumoto T. 2002. Inflammatory and antiinflammatory cytokines regulate the recovery from sublethal X irradiation in rat thymus. Radiation Research 157(3): 281-289.
51. Mole R, Papworth DG, Corp MJ. 1983. The dose-response for xray induction of myeloid leukemia in male CBA/H mice. British Journal of Cancer 47(2):285-291.
52. Moore SR, Marsden S, Macdonald D, Mitchell S, Folkard M, Michael B, Goodhead DT, Prise KM, Kadhim MA. 2005. Genomic instability in human lymphocytes irradiated with individual charged particles: Involvement of tumor necrosis factor alpha in irradiated cells but not bystander cells. Radiation Research 163(2):183-190.
53. Mounzer KC, Moncure M, Smith YR, Dinubile MJ. 1999. Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma. American Journal of Respiratory and Critical Care Medicine 160(5): 1673-1681.
54. Murata H, Shimada N, Yoshioka M. 2004. Current research on acute phase proteins in veterinary diagnosis: An overview. Veterinary Journal 168(1):28-40.
55. Nakagawa-Tosa N, Morimatsu M, Kawasaki M, Nakatsuji H, Syuto B, Saito M. 1995. Stimulation of haptoglobin synthesis by interleukin-6 and tumor necrosis factor, but not by interleukin-1, in bovine primary cultured hepatocytes. Journal of Veterinary Medical Science 57(2):219-223.
56. Oberemm A, Onyon L, Gundert-Remy U. 2005. How can toxicogenomics inform risk assessment? Toxicology and Applied Pharmacology 207(2, Suppl. 1):592-598.
57. PHS. 2002. Public Health Services: Policy on Humane Care and Use of Laboratory Animals. In: Services UDoHaH, editor. Washington DC.
58. Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. 1996. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiation Research 146(1):1-27.
59. Rithidech KN, Cronkite EP, Bond VP. 1999. Advantages of the CBA mouse in leukemogenesis research. Blood Cells Molecular and Diseases 25(1):38-45.
60. Rithidech KN, Honikel L, Simon SR. 2007. Radiation leukemogenesis: A proteomic approach. Experimental Hematology 35(4, Suppl. 1):117-124.
61. 56Fe ions 2008; Montreal, Committee on Space Research Scientific Assembly.
62. Rodland KD. 2004. Proteomics and cancer diagnosis: The potential of mass spectrometry. Clinical Biochemistry 37(7): 579-583.
63. Smith DB, Janmey PA, Lind SE. 1988. Circulating actin-gelsolin complexes following oleic acid-induced lung injury. American Journal of Pathology 130(2):261-267.
64. Steel LF, Trotter MG, Nakajima PB, Mattu TS, Gonye G, Block T. 2003. Efficient and specific removal of albumin from human serum samples. Molecular Cellular Proteomics 2(4): 262-270.
65. Trutic N, Magic Z, Urosevic N, Krtolica K. 2002. Acute-phase protein gene expression in rat liver following whole body X-irradiation or partial hepatectomy. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 133(3):461-470.
66. Wang AY-M, Woo J, Lam CW-K, Wang M, Chan IH-S, Gao P, Lui S-F, Li PK-T, Sanderson JE. 2005. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrology Dialysis Transplantation 20(8): 1676-1685.
67. Wassell J. 2000. Haptoglobin: Function and polymorphism. Clinical Laboratory 46(11-12):547-552.
68. Witzmann FA, Richardson MR. 2006. Two-dimensional gels for toxicological drug discovery applications. Expert Opinion on Drug Metabolism and Toxicology 2(1):103-111.
69. Yang C-R, Leskov K, Hosley-Eberlein K, Criswell T, Pink JJ, Kinsella TJ, Boothman DA. 2000. Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death. Proceedings of National Academy of Sciences 97(11): 5907-5912.
70. Yang F, Stenoien DL, Strittmatter EF, Wang J, Ding L, Lipton MS, Monroe ME, Nicora CD, Gristenko MA, Tang K, Fang R, Adkins JN, Camp DG, 2nd, Chen DJ, Smith RD. 2006. Phosphoproteome profiling of human skin fibroblast cells in response to low- and high-dose irradiation. Journal of Proteome Research 5(5):1252-1260.
71. Yasuda S, Atsumi T, Ieko M, Koike T. 2004. [beta]2-glycoprotein I, anti-[beta]2-glycoprotein I, and fibrinolysis. Thrombosis Research 114(5-6):461-465.
72. Zhang B, Su YP, Ai GP, Liu XH, Wang FC, Cheng TM. 2003. Differentially expressed proteins of gamma-ray irradiated mouse intestinal epithelial cells by two-dimensional electro-phoresis and MALDI-TOF mass spectrometry. World Journal Gastroenterology 9(12):2726-2731.
73. Zolotarjova N, Martosella J, Nicol G, Bailey J, Boyes BE, Barrett WC. 2005. Differences among techniques for high-abundant protein depletion. Proteomics 5(13): 3304-3313.